Detalhe da pesquisa
1.
Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation.
Immunity
; 56(10): 2325-2341.e15, 2023 Oct 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37652021
2.
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
Blood
; 133(2): 137-146, 2019 01 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30341058
3.
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study.
Lancet Oncol
; 21(7): 978-988, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32511983
4.
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.
N Engl J Med
; 377(14): 1331-1344, 2017 10 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28976863
5.
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL.
Blood
; 131(9): 955-962, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29255066
6.
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study.
Haematologica
; 105(9): 2298-2307, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33054054
7.
Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion.
J Cell Mol Med
; 23(6): 3867-3877, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30968541
8.
Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab-refractory follicular lymphoma patients in the GADOLIN phase III study.
Br J Clin Pharmacol
; 85(9): 1935-1945, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31050355
9.
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first-line immunochemotherapy.
Br J Clin Pharmacol
; 85(7): 1495-1506, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30866056
10.
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
Am J Hematol
; 94(9): 1002-1006, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31222797
11.
Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.
Mol Ther
; 26(10): 2523-2532, 2018 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30077612
12.
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1530-1542, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30309758
13.
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 17(8): 1081-1093, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27345636
14.
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab.
Blood
; 133(5): 494-497, 2019 01 31.
Artigo
Inglês
| MEDLINE | ID: mdl-30455380
15.
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.
Blood
; 123(21): 3247-54, 2014 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-24652989
16.
Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
Mol Med
; 20: 729-35, 2015 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-25826675
17.
CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia.
Blood
; 121(20): 4126-36, 2013 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-23547049
18.
Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
Blood
; 121(5): 812-21, 2013 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-23118218
19.
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.
Cytokine
; 72(2): 135-45, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25647268
20.
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
Nat Med
; 13(5): 587-96, 2007 May.
Artigo
Inglês
| MEDLINE | ID: mdl-17435771